United Therapeutics chairperson, CEO Martine Rothblatt disposes of shares worth $4.91 million
UTHR•United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised options for 9,500 shares on Oct. 5, 2026, while a family trust sold 8,500 shares. The headline values the shares disposed of at $4.91 million.
1. Option exercise and sale
Rothblatt exercised stock options for 9,500 shares at $117.76 each on Oct. 5, 2026. A family trust sold 8,500 shares that day at weighted-average prices ranging from $536.2579 to $546.6322; its holdings fell to 324,443 shares, while its stock options rose to 299,910.
